Verification evidence is still being completed.
PDF / print export
Epithelix Sarl
Plan-les-Ouates, Switzerland
- Verified lead
- Samuel Constant
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer and Co-Founder
- 2026 technical specialization
- In Vitro Airway Epithelial Models, MucilAir and SmallAir, and Alternative Testing Platforms
- Review cycle
- 24 April 2026
- Full address
- 14 chemin des aulx, CH-1228 Plan-les-Ouates, Geneva, Switzerland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Adebiotech presentation naming Samuel Constant PhD as CEO of Epithelix.
- Editorial note
- Plan-les-Ouates 3D airway model specialist with named co-founder CEO, MucilAir and SmallAir commercial product lines, and peer-reviewed validation.
In Vitro Airway Epithelial Models, MucilAir and SmallAir, and Alternative Testing Platforms
Peer-reviewed scientific publications, Public CEO disclosure, Alternative-testing customer base
Plan-les-Ouates 3D airway model specialist with named co-founder CEO, MucilAir and SmallAir commercial product lines, and peer-reviewed validation.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Plan-les-Ouates, Switzerland
Epithelix Sarl
In Vitro Airway Epithelial Models, MucilAir and SmallAir, and Alternative Testing Platforms · Commercial in vitro tissue manufacturing
Plan-les-Ouates 3D airway model specialist with named co-founder CEO, MucilAir and SmallAir commercial product lines, and peer-reviewed validation.
- Lead
- Samuel Constant (verified ↗)
- Address
- 14 chemin des aulx, CH-1228 Plan-les-Ouates, Geneva, Switzerland (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- Commercial in vitro tissue manufacturing
- Capabilities
- MucilAir 3D Upper Airway Models · SmallAir Small Airway Epithelial Models · Alternative Testing and ALI Culture Services
- Founded
- 2006
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED APRIL 2026
Samuel Constant
Chief Executive Officer and Co-Founder
Full address14 chemin des aulx, CH-1228 Plan-les-Ouates, Geneva, Switzerland
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Commercial in vitro tissue manufacturing
Plan-les-Ouates, Switzerland. In Vitro Airway Epithelial Models, MucilAir and SmallAir, and Alternative Testing Platforms. Review completed on 24 Apr 2026.
Swiss quality standards for research tools
Peer-reviewed scientific publications, Public CEO disclosure, Alternative-testing customer base
In Vitro Airway Epithelial Models, MucilAir and SmallAir, and Alternative Testing Platforms
Plan-les-Ouates 3D airway model specialist with named co-founder CEO, MucilAir and SmallAir commercial product lines, and peer-reviewed validation.
Editorial note
Epithelix is a Plan-les-Ouates specialist in 3D airway epithelial models with a named co-founder CEO, marketed MucilAir and SmallAir product lines, and a documented scientific-publication trail validating both platforms.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
MucilAir 3D Upper Airway Models
SmallAir Small Airway Epithelial Models
Alternative Testing and ALI Culture Services
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Air-liquid interface culture workflow
Primary human airway cell expansion
Quality-control characterization laboratories
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Epithelix Sarl located?
- Epithelix Sarl operates from 14 chemin des aulx, CH-1228 Plan-les-Ouates, Geneva, Switzerland, Plan-les-Ouates, Switzerland.
- Who runs Epithelix Sarl?
- Epithelix Sarl is led by Samuel Constant, Chief Executive Officer and Co-Founder. Verified 24 Apr 2026.
- What does Epithelix Sarl do?
- Plan-les-Ouates 3D airway model specialist with named co-founder CEO, MucilAir and SmallAir commercial product lines, and peer-reviewed validation. Core capabilities: MucilAir 3D Upper Airway Models, SmallAir Small Airway Epithelial Models, Alternative Testing and ALI Culture Services.
Editorial context
Related technical briefs
Briefs that name Plan-les-Ouates as a covered market or city.